Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

P2939000

Prilocaine

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

(±)-2′-Methyl-2-(propylamino)propionanilide, N-(2-Methylphenyl)-2-(propylamino)propanamide

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C13H20N2O
Numero CAS:
721-50-6
Peso molecolare:
220.31
Codice UNSPSC:
41116107
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

prilocaine

Produttore/marchio commerciale

EDQM

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

N(C(C)C(=O)Nc1c(cccc1)C)CCC

InChI

1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16)
MVFGUOIZUNYYSO-UHFFFAOYSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Prilocaine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

1561019

Prilocaine Related Compound A, United States Pharmacopeia (USP) Reference Standard

P2939025

Prilocaine impurity E, European Pharmacopoeia (EP) Reference Standard

P2939060

Prilocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0001408

Prilocaine impurity B, European Pharmacopoeia (EP) Reference Standard

1561008

Prilocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard

1561020

Prilocaine Related Compound B, United States Pharmacopeia (USP) Reference Standard

1560990

Prilocaine, United States Pharmacopeia (USP) Reference Standard

Y0001681

Prilocaine for peak identification, European Pharmacopoeia (EP) Reference Standard

BP497

Prilocaine hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR3105

Prilocaine, pharmaceutical secondary standard, certified reference material

PHR3106

Prilocaine Hydrochloride, pharmaceutical secondary standard, certified reference material

PHR3107

Prilocaine Related Compound A, pharmaceutical secondary standard, certified reference material

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302,H319

Classi di pericolo

Acute Tox. 4 Oral - Eye Irrit. 2

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 1

1 of 1

Sodio idrossido BioXtra, ≥98% (acidimetric), pellets (anhydrous)

Sigma-Aldrich

S8045

Sodio idrossido

M Y Hyun et al.
Clinical and experimental dermatology, 40(2), 129-135 (2014-10-17)
Hyaluronic acid (HA) fillers and poly-L-lactic acid (PLA) fillers are frequently used to correct facial wrinkles. To compare the efficacy and safety of a novel injectable poly-L-lactic acid (PLA) filler and a well-studied biphasic HA filler for the treatment of
Elena I Gubanova et al.
Journal of drugs in dermatology : JDD, 14(3), 288-298 (2015-03-05)
In this evaluator-blind, placebo-controlled study, microinjections of stabilized hyaluronic acid (HA) gel for rejuvenation of aging hands were evaluated. Patients received three injections of 1.0 ml HA gel (20 mg/ml HA) in the dorsum of one hand and 1.0 ml
Murad Alam et al.
JAMA dermatology, 150(8), 844-849 (2014-06-13)
Neocollagenesis can be achieved using a dermal rolling needle device, thereby reducing the appearance of acne scars. To determine the efficacy of a needling device for treatment of acne scars. We performed a single-center, rater-blinded, balanced (1:1), split-face, placebo-controlled, parallel-group
Hee Jung Lee et al.
The Journal of dermatological treatment, 26(1), 73-77 (2014-02-12)
Intense focused ultrasound (IFUS) has been used successfully for skin tightening. To investigate the efficacy of IFUS in treating enlarged pores and to evaluate changes in skin elasticity and sebum production following IFUS. Twenty-two subjects with enlarged pores were randomized
Adam Rish
Journal of cosmetic dermatology, 13(4), 253-260 (2014-11-18)
A review of 242 facial treatments, in 86 different patients, with polyacrylamide gel (PAAG) was carried out by the author between 2003 and 2013. To evaluate by retrospective study the long-term outcomes of PAAG filling for facial contouring. To quantify
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.